Allergy Relief (cetirizine tablets) NDC 53943-130

NDC codes

FDA NDC Directory

Product NDC (as listed)53943-130Labeler and product segments. Claims need a package NDC.

Product NDC at billing width53943-0130Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
53943-130-13	53943013013	1 BOTTLE, PLASTIC in 1 CARTON (53943-130-13) / 30 TABLET, FILM COATED in 1 BOTTLE, PLASTICMarketed from May 20, 2026
53943-130-17	53943013017	1 BOTTLE, PLASTIC in 1 CARTON (53943-130-17) / 60 TABLET, FILM COATED in 1 BOTTLE, PLASTICMarketed from May 20, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Allergy Relief
Generic name (nonproprietary): cetirizine tablets
Active ingredients: Cetirizine hydrochloride — 10 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: DISCOUNT DRUG MART, INC
Product type: Over-the-counter drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078862
Marketing start: May 20, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Histamine H1 Receptor Antagonists (Mechanism)
Identifiers: Product ID 53943-130_502476ab-e17d-bf5a-e063-6294a90a84feSPL ID 502476ab-e17d-bf5a-e063-6294a90a84feSPL set ID 4b9576dc-d7f9-dc10-e063-6294a90a233eRxCUI 1014678UNII 64O047KTOA
Pharmacologic class: Histamine-1 Receptor Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N453943013013 followed by a unit qualifier and the quantity

Package 53943-0130-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 23, 2026.

Indications (excerpt from the label)

Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 078862

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078862
Product	Strength	Form · route	Labeler	Product NDC
Cetirizine Hydrochloride	Cetirizine hydrochloride 10 mg/1	Tablet, Film coatedOral	Bionpharma Inc.	69452-465
Hives Reliefcetirizine tablets	Cetirizine hydrochloride 10 mg/1	Tablet, Film coatedOral	WALGREEN COMPANY	0363-6340